Principia Biopharma

Developer of small-molecule drugs targeting autoimmune diseases and cancer

placeSan Francisco, California, United States calendar_todayFounded 2011 groups122 employees language principiabio.com

Registered entities

Investor mix

11 investors on record; lead investors include Sofinnova Investments; 1 has since exited.

Investor typeCountShare
Venture capital1091%
Private equity19%
Coming soon